Skip to main content
Tech.euFundingExplorerBeta

LenioBio

LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.

LenioBio has raised €16M across 3 funding rounds from 3 investors, most recently a Grant round in Jul 2025. Based in Dusseldorf, Germany; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€16M
€16,100,000
Funding rounds
3
Investors
3
distinct backers
Active since
2022-03
latest 2025-07

Funding by year

EUR raised per year
LenioBio — funding by year — interactive chart.
Data table
LenioBio — funding by year
2022€12M
2023€900k
2025€3.7M

Signals

High confidence
Raise-next likelihood54
base rate 45% for Grant
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2025-07-28Grant€3.7MEuropean Health and Digital Executive Agency (HaDEA)View deal →
2023-09-14Grant€900kEIT FoodView deal →
2022-03-08Series A€12MBridford GroupView deal →

Similar companies

same sector or country

Global coverage: FundingData